Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16051062rdf:typepubmed:Citationlld:pubmed
pubmed-article:16051062lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:16051062lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:16051062lifeskim:mentionsumls-concept:C0008151lld:lifeskim
pubmed-article:16051062lifeskim:mentionsumls-concept:C0383327lld:lifeskim
pubmed-article:16051062lifeskim:mentionsumls-concept:C0221908lld:lifeskim
pubmed-article:16051062lifeskim:mentionsumls-concept:C0022688lld:lifeskim
pubmed-article:16051062lifeskim:mentionsumls-concept:C0011306lld:lifeskim
pubmed-article:16051062lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:16051062lifeskim:mentionsumls-concept:C1819433lld:lifeskim
pubmed-article:16051062lifeskim:mentionsumls-concept:C1819439lld:lifeskim
pubmed-article:16051062lifeskim:mentionsumls-concept:C1522538lld:lifeskim
pubmed-article:16051062pubmed:issue2lld:pubmed
pubmed-article:16051062pubmed:dateCreated2005-7-29lld:pubmed
pubmed-article:16051062pubmed:abstractTextControl of infection by Chlamydia trachomatis usually requires the production of interferon-gamma. Whilst this can be produced by CD4+ and CD8+ T lymphocytes, natural killer (NK) cells are another important source of this cytokine, and are known to be recruited early to the infected genital tract. We show that both IL-12 and IL-18, which synergise to stimulate NK cells to produce interferon-gamma, are produced following the infection of dendritic cells and epithelial cells respectively, since supernatants from infected cells could substitute for recombinant cytokines. These results suggest that conditions, which lead to NK cell production of interferon-gamma will be present at the site of infection, where epithelial cells are the primary targets of infection and dendritic cells within the epithelium can also access the bacterium.lld:pubmed
pubmed-article:16051062pubmed:languageenglld:pubmed
pubmed-article:16051062pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051062pubmed:citationSubsetIMlld:pubmed
pubmed-article:16051062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16051062pubmed:statusMEDLINElld:pubmed
pubmed-article:16051062pubmed:monthAuglld:pubmed
pubmed-article:16051062pubmed:issn0928-8244lld:pubmed
pubmed-article:16051062pubmed:authorpubmed-author:MatyszakMalgo...lld:pubmed
pubmed-article:16051062pubmed:authorpubmed-author:HookCatherina...lld:pubmed
pubmed-article:16051062pubmed:authorpubmed-author:GastonJohn...lld:pubmed
pubmed-article:16051062pubmed:issnTypePrintlld:pubmed
pubmed-article:16051062pubmed:day1lld:pubmed
pubmed-article:16051062pubmed:volume45lld:pubmed
pubmed-article:16051062pubmed:ownerNLMlld:pubmed
pubmed-article:16051062pubmed:authorsCompleteYlld:pubmed
pubmed-article:16051062pubmed:pagination113-20lld:pubmed
pubmed-article:16051062pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:meshHeadingpubmed-meshheading:16051062...lld:pubmed
pubmed-article:16051062pubmed:year2005lld:pubmed
pubmed-article:16051062pubmed:articleTitleInfection of epithelial and dendritic cells by Chlamydia trachomatis results in IL-18 and IL-12 production, leading to interferon-gamma production by human natural killer cells.lld:pubmed
pubmed-article:16051062pubmed:affiliationDepartment of Medicine, University of Cambridge School of Clinical Medicine, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK.lld:pubmed
pubmed-article:16051062pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:3458entrezgene:pubmedpubmed-article:16051062lld:entrezgene
entrez-gene:3606entrezgene:pubmedpubmed-article:16051062lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16051062lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:16051062lld:entrezgene
lhgdn:association:3227lhgdn:found_inpubmed-article:16051062lld:lhgdn
lhgdn:association:14588lhgdn:found_inpubmed-article:16051062lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051062lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051062lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16051062lld:pubmed